25 XP   0   0   10

Ortin Laboratories Limited
Buy, Hold or Sell?

Let's analyse Ortin Laboratories Limited together

PenkeI guess you are interested in Ortin Laboratories Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Ortin Laboratories Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Ortin Laboratories Limited

I send you an email if I find something interesting about Ortin Laboratories Limited.

Quick analysis of Ortin Laboratories Limited (30 sec.)










What can you expect buying and holding a share of Ortin Laboratories Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
INR13.36
Expected worth in 1 year
INR12.91
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
INR-0.45
Return On Investment
-2.3%

For what price can you sell your share?

Current Price per Share
INR20.00
Expected price per share
INR16.20 - INR22.60
How sure are you?
50%

1. Valuation of Ortin Laboratories Limited (5 min.)




Live pricePrice per Share (EOD)

INR20.00

Intrinsic Value Per Share

INR-34.03 - INR89.55

Total Value Per Share

INR-20.66 - INR102.91

2. Growth of Ortin Laboratories Limited (5 min.)




Is Ortin Laboratories Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$1.3m$1.3m-$11k-0.8%

How much money is Ortin Laboratories Limited making?

Current yearPrevious yearGrowGrow %
Making money-$8k-$47.8k$39.8k496.0%
Net Profit Margin-1.1%-4.8%--

How much money comes from the company's main activities?

3. Financial Health of Ortin Laboratories Limited (5 min.)




What can you expect buying and holding a share of Ortin Laboratories Limited? (5 min.)

Welcome investor! Ortin Laboratories Limited's management wants to use your money to grow the business. In return you get a share of Ortin Laboratories Limited.

What can you expect buying and holding a share of Ortin Laboratories Limited?

First you should know what it really means to hold a share of Ortin Laboratories Limited. And how you can make/lose money.

Speculation

The Price per Share of Ortin Laboratories Limited is INR20.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ortin Laboratories Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ortin Laboratories Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR13.36. Based on the TTM, the Book Value Change Per Share is INR-0.11 per quarter. Based on the YOY, the Book Value Change Per Share is INR-0.46 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ortin Laboratories Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.000.0%0.000.0%-0.010.0%0.000.0%0.010.0%
Usd Book Value Change Per Share0.000.0%0.000.0%-0.010.0%-0.04-0.2%-0.01-0.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.000.0%-0.010.0%-0.04-0.2%-0.01-0.1%
Usd Price Per Share0.21-0.21-0.27-0.20-0.13-
Price to Earnings Ratio-152.46--152.46--46.09--34.57--13.24-
Price-to-Total Gains Ratio-155.31--155.31--49.38--40.72--19.88-
Price to Book Ratio1.31-1.31-1.68-1.11-0.65-
Price-to-Total Gains Ratio-155.31--155.31--49.38--40.72--19.88-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.24
Number of shares4166
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.00-0.04
Usd Total Gains Per Share0.00-0.04
Gains per Quarter (4166 shares)-5.65-162.47
Gains per Year (4166 shares)-22.60-649.88
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-23-330-650-660
20-45-560-1300-1310
30-68-790-1950-1960
40-90-1020-2600-2610
50-113-1250-3249-3260
60-136-1480-3899-3910
70-158-1710-4549-4560
80-181-1940-5199-5210
90-203-2170-5849-5860
100-226-2400-6499-6510

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%7.03.00.070.0%12.03.00.080.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%6.04.00.060.0%11.04.00.073.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.015.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%6.04.00.060.0%11.04.00.073.3%

Fundamentals of Ortin Laboratories Limited

About Ortin Laboratories Limited

Ortin Laboratories Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders. It provides formulations, such as anti-diabetics, anti allergics, sedatives and tranquilisers, anti helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides; and anti-anginal and cardio vascular, and antifungal products. Its formulations also include chemo therapeutics, antacids and anti ulcerants, anti spasmodics, calcium and iron preparations, anti-arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti-retroviral products. In addition, the company offers active pharmaceutical ingredient (API) intermediates, including anti retro viral, anti-diabetics, analgesics and antipyretics, anti-biotics, antifungal, antacids and anti ulcerants, and anti malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company provides services in the areas of process development, process and product characterization, analytical research and development, and assay development; and diagnostic services comprising development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs; and operates as a merchant exporter of pharmaceutical finished formulations. Ortin Laboratories Limited was incorporated in 1986 and is headquartered in Hyderabad, India.

Fundamental data was last updated by Penke on 2024-04-24 09:11:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Ortin Laboratories Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Ortin Laboratories Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Ortin Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -1.1% means that ₹-0.01 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ortin Laboratories Limited:

  • The MRQ is -1.1%. The company is making a loss. -1
  • The TTM is -1.1%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-1.1%TTM-1.1%0.0%
TTM-1.1%YOY-4.8%+3.7%
TTM-1.1%5Y1.2%-2.3%
5Y1.2%10Y1.4%-0.2%
1.1.2. Return on Assets

Shows how efficient Ortin Laboratories Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ortin Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • -0.3% Return on Assets means that Ortin Laboratories Limited generated ₹0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ortin Laboratories Limited:

  • The MRQ is -0.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.3%TTM-0.3%0.0%
TTM-0.3%YOY-1.9%+1.6%
TTM-0.3%5Y0.6%-0.9%
5Y0.6%10Y0.9%-0.3%
1.1.3. Return on Equity

Shows how efficient Ortin Laboratories Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ortin Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • -0.6% Return on Equity means Ortin Laboratories Limited generated ₹-0.01 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ortin Laboratories Limited:

  • The MRQ is -0.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -0.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.6%TTM-0.6%0.0%
TTM-0.6%YOY-3.6%+3.0%
TTM-0.6%5Y1.4%-2.0%
5Y1.4%10Y2.4%-1.1%

1.2. Operating Efficiency of Ortin Laboratories Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Ortin Laboratories Limited is operating .

  • Measures how much profit Ortin Laboratories Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ortin Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 5.2% means the company generated ₹0.05  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ortin Laboratories Limited:

  • The MRQ is 5.2%. The company is operating less efficient.
  • The TTM is 5.2%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ5.2%TTM5.2%0.0%
TTM5.2%YOY3.1%+2.1%
TTM5.2%5Y5.0%+0.2%
5Y5.0%10Y7.1%-2.1%
1.2.2. Operating Ratio

Measures how efficient Ortin Laboratories Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.95 means that the operating costs are ₹0.95 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Ortin Laboratories Limited:

  • The MRQ is 0.948. The company is less efficient in keeping operating costs low.
  • The TTM is 0.948. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.948TTM0.9480.000
TTM0.948YOY0.970-0.022
TTM0.9485Y0.950-0.002
5Y0.95010Y0.930+0.021

1.3. Liquidity of Ortin Laboratories Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Ortin Laboratories Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.94 means the company has ₹0.94 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Ortin Laboratories Limited:

  • The MRQ is 0.936. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.936. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.936TTM0.9360.000
TTM0.936YOY0.756+0.181
TTM0.9365Y0.942-0.005
5Y0.94210Y1.051-0.109
1.3.2. Quick Ratio

Measures if Ortin Laboratories Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ortin Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.53 means the company can pay off ₹0.53 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ortin Laboratories Limited:

  • The MRQ is 0.531. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.531. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.531TTM0.5310.000
TTM0.531YOY0.517+0.014
TTM0.5315Y0.544-0.012
5Y0.54410Y0.567-0.023

1.4. Solvency of Ortin Laboratories Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Ortin Laboratories Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ortin Laboratories Limited to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.49 means that Ortin Laboratories Limited assets are financed with 48.7% credit (debt) and the remaining percentage (100% - 48.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Ortin Laboratories Limited:

  • The MRQ is 0.487. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.487. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.487TTM0.4870.000
TTM0.487YOY0.471+0.017
TTM0.4875Y0.596-0.109
5Y0.59610Y0.628-0.031
1.4.2. Debt to Equity Ratio

Measures if Ortin Laboratories Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ortin Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 95.1% means that company has ₹0.95 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ortin Laboratories Limited:

  • The MRQ is 0.951. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.951. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.951TTM0.9510.000
TTM0.951YOY0.890+0.061
TTM0.9515Y1.959-1.008
5Y1.95910Y1.956+0.003

2. Market Valuation of Ortin Laboratories Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Ortin Laboratories Limited generates.

  • Above 15 is considered overpriced but always compare Ortin Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -152.46 means the investor is paying ₹-152.46 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ortin Laboratories Limited:

  • The EOD is -173.748. Based on the earnings, the company is expensive. -2
  • The MRQ is -152.464. Based on the earnings, the company is expensive. -2
  • The TTM is -152.464. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-173.748MRQ-152.464-21.284
MRQ-152.464TTM-152.4640.000
TTM-152.464YOY-46.089-106.374
TTM-152.4645Y-34.566-117.898
5Y-34.56610Y-13.243-21.323
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ortin Laboratories Limited:

  • The EOD is -65.975. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -57.893. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -57.893. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-65.975MRQ-57.893-8.082
MRQ-57.893TTM-57.8930.000
TTM-57.893YOY9.066-66.959
TTM-57.8935Y-2.877-55.016
5Y-2.87710Y-5.551+2.674
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Ortin Laboratories Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 1.31 means the investor is paying ₹1.31 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Ortin Laboratories Limited:

  • The EOD is 1.497. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.313. Based on the equity, the company is underpriced. +1
  • The TTM is 1.313. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.497MRQ1.313+0.183
MRQ1.313TTM1.3130.000
TTM1.313YOY1.677-0.364
TTM1.3135Y1.113+0.201
5Y1.11310Y0.653+0.459
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Ortin Laboratories Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.113-0.1130%-0.458+305%-3.250+2776%-1.200+962%
Book Value Per Share--13.36213.3620%13.475-1%20.184-34%24.271-45%
Current Ratio--0.9360.9360%0.756+24%0.942-1%1.051-11%
Debt To Asset Ratio--0.4870.4870%0.471+4%0.596-18%0.628-22%
Debt To Equity Ratio--0.9510.9510%0.890+7%1.959-51%1.956-51%
Dividend Per Share----0%-0%-0%-0%
Eps---0.115-0.1150%-0.490+326%0.287-140%0.634-118%
Free Cash Flow Per Share---0.303-0.3030%2.493-112%5.670-105%2.280-113%
Free Cash Flow To Equity Per Share--0.8090.8090%1.908-58%2.391-66%0.962-16%
Gross Profit Margin--2.9332.9330%2.474+19%2.147+37%1.372+114%
Intrinsic Value_10Y_max--89.547--------
Intrinsic Value_10Y_min---34.027--------
Intrinsic Value_1Y_max--8.311--------
Intrinsic Value_1Y_min--0.854--------
Intrinsic Value_3Y_max--25.476--------
Intrinsic Value_3Y_min---1.111--------
Intrinsic Value_5Y_max--43.250--------
Intrinsic Value_5Y_min---7.093--------
Market Cap162627800.000+12%142705929.600142705929.6000%183769459.200-22%132923264.896+7%89468700.630+60%
Net Profit Margin---0.011-0.0110%-0.048+336%0.012-191%0.014-177%
Operating Margin--0.0520.0520%0.031+67%0.050+3%0.071-27%
Operating Ratio--0.9480.9480%0.970-2%0.9500%0.930+2%
Pb Ratio1.497+12%1.3131.3130%1.677-22%1.113+18%0.653+101%
Pe Ratio-173.748-14%-152.464-152.4640%-46.089-70%-34.566-77%-13.243-91%
Price Per Share20.000+12%17.55017.5500%22.600-22%16.332+7%10.991+60%
Price To Free Cash Flow Ratio-65.975-14%-57.893-57.8930%9.066-739%-2.877-95%-5.551-90%
Price To Total Gains Ratio-176.989-14%-155.308-155.3080%-49.376-68%-40.720-74%-19.882-87%
Quick Ratio--0.5310.5310%0.517+3%0.544-2%0.567-6%
Return On Assets---0.003-0.0030%-0.019+510%0.006-154%0.009-136%
Return On Equity---0.006-0.0060%-0.036+491%0.014-145%0.024-125%
Total Gains Per Share---0.113-0.1130%-0.458+305%-3.250+2776%-1.200+962%
Usd Book Value--1303788.0001303788.0000%1314814.272-1%1970090.340-34%2370048.023-45%
Usd Book Value Change Per Share---0.001-0.0010%-0.005+305%-0.039+2776%-0.014+962%
Usd Book Value Per Share--0.1600.1600%0.162-1%0.242-34%0.291-45%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.001-0.0010%-0.006+326%0.003-140%0.008-118%
Usd Free Cash Flow---29580.000-29580.0000%243243.708-112%554264.474-105%222922.463-113%
Usd Free Cash Flow Per Share---0.004-0.0040%0.030-112%0.068-105%0.027-113%
Usd Free Cash Flow To Equity Per Share--0.0100.0100%0.023-58%0.029-66%0.012-16%
Usd Market Cap1951533.600+12%1712471.1551712471.1550%2205233.510-22%1595079.179+7%1073624.408+60%
Usd Price Per Share0.240+12%0.2110.2110%0.271-22%0.196+7%0.132+60%
Usd Profit---8028.000-8028.0000%-47847.156+496%28702.207-128%62237.291-113%
Usd Revenue--722436.000722436.0000%987695.436-27%9164194.411-92%7674053.105-91%
Usd Total Gains Per Share---0.001-0.0010%-0.005+305%-0.039+2776%-0.014+962%
 EOD+5 -3MRQTTM+0 -0YOY+19 -155Y+14 -2010Y+12 -22

3.2. Fundamental Score

Let's check the fundamental score of Ortin Laboratories Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-173.748
Price to Book Ratio (EOD)Between0-11.497
Net Profit Margin (MRQ)Greater than0-0.011
Operating Margin (MRQ)Greater than00.052
Quick Ratio (MRQ)Greater than10.531
Current Ratio (MRQ)Greater than10.936
Debt to Asset Ratio (MRQ)Less than10.487
Debt to Equity Ratio (MRQ)Less than10.951
Return on Equity (MRQ)Greater than0.15-0.006
Return on Assets (MRQ)Greater than0.05-0.003
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Ortin Laboratories Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.601
Ma 20Greater thanMa 5019.583
Ma 50Greater thanMa 10019.547
Ma 100Greater thanMa 20020.594
OpenGreater thanClose19.750
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets211,971
Total Liabilities103,322
Total Stockholder Equity108,649
 As reported
Total Liabilities 103,322
Total Stockholder Equity+ 108,649
Total Assets = 211,971

Assets

Total Assets211,971
Total Current Assets65,365
Long-term Assets146,606
Total Current Assets
Cash And Cash Equivalents 2,198
Short-term Investments 361
Net Receivables 34,174
Inventory 25,984
Other Current Assets 2,648
Total Current Assets  (as reported)65,365
Total Current Assets  (calculated)65,365
+/-0
Long-term Assets
Property Plant Equipment 143,899
Other Assets 2,707
Long-term Assets  (as reported)146,606
Long-term Assets  (calculated)146,606
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities69,802
Long-term Liabilities33,520
Total Stockholder Equity108,649
Total Current Liabilities
Short-term Debt 34,841
Short Long Term Debt 34,841
Accounts payable 15,472
Other Current Liabilities 18,481
Total Current Liabilities  (as reported)69,802
Total Current Liabilities  (calculated)103,635
+/- 33,833
Long-term Liabilities
Long term Debt 29,626
Other Liabilities 3,894
Long-term Liabilities  (as reported)33,520
Long-term Liabilities  (calculated)33,520
+/-0
Total Stockholder Equity
Common Stock81,314
Retained Earnings 20,882
Accumulated Other Comprehensive Income 6,453
Total Stockholder Equity (as reported)108,649
Total Stockholder Equity (calculated)108,649
+/-0
Other
Capital Stock81,314
Cash and Short Term Investments 2,559
Common Stock Shares Outstanding 8,131
Current Deferred Revenue1,008
Liabilities and Stockholders Equity 211,971
Net Debt 62,269
Net Invested Capital 173,116
Net Tangible Assets 108,649
Net Working Capital -4,437
Property Plant and Equipment Gross 143,899
Short Long Term Debt Total 64,467



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-31
> Total Assets 
0
148,912
145,150
545,666
830,540
734,918
725,672
672,679
653,363
614,094
736,634
1,050,862
1,165,178
212,659
207,047
211,971
211,971207,047212,6591,165,1781,050,862736,634614,094653,363672,679725,672734,918830,540545,666145,150148,9120
   > Total Current Assets 
0
115,067
104,996
316,498
578,148
463,957
464,643
433,474
419,555
289,269
523,551
820,402
924,120
61,253
57,496
65,365
65,36557,49661,253924,120820,402523,551289,269419,555433,474464,643463,957578,148316,498104,996115,0670
       Cash And Cash Equivalents 
0
37,433
22,186
1,915
10,065
10,414
2,586
8,279
7,535
5,203
7,660
8,908
9,624
251
4,919
2,198
2,1984,9192519,6248,9087,6605,2037,5358,2792,58610,41410,0651,91522,18637,4330
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
3,181
0
0
1,509
1,032
361
3611,0321,509003,1810000000000
       Net Receivables 
0
0
0
270,051
455,974
301,122
244,622
205,097
243,224
106,557
263,362
441,923
415,590
39,146
33,393
34,174
34,17433,39339,146415,590441,923263,362106,557243,224205,097244,622301,122455,974270,051000
       Other Current Assets 
0
69,900
72,151
884
1,466
207
207
342
396
1,008
12,336
1
-100
2,028
1,775
2,648
2,6481,7752,028-100112,3361,0083963422072071,46688472,15169,9000
   > Long-term Assets 
0
33,846
40,155
229,168
252,392
270,961
261,029
239,206
233,808
324,826
213,083
230,460
241,057
151,406
149,551
146,606
146,606149,551151,406241,057230,460213,083324,826233,808239,206261,029270,961252,392229,16840,15533,8460
       Property Plant Equipment 
0
30,946
38,222
226,879
238,498
247,691
238,983
218,345
216,273
210,414
204,362
218,205
228,814
148,062
146,378
143,899
143,899146,378148,062228,814218,205204,362210,414216,273218,345238,983247,691238,498226,87938,22230,9460
       Other Assets 
0
0
0
0
0
0
0
0
0
0
7,923
11,415
1
3,344
3,173
2,707
2,7073,1733,344111,4157,9230000000000
> Total Liabilities 
0
83,360
75,780
346,773
628,753
527,162
506,052
448,293
420,638
377,438
495,853
799,922
927,019
99,104
97,479
103,322
103,32297,47999,104927,019799,922495,853377,438420,638448,293506,052527,162628,753346,77375,78083,3600
   > Total Current Liabilities 
0
21,918
39,421
214,397
598,629
487,388
447,157
368,173
340,693
263,759
416,224
721,756
838,271
78,860
76,102
69,802
69,80276,10278,860838,271721,756416,224263,759340,693368,173447,157487,388598,629214,39739,42121,9180
       Short-term Debt 
0
0
0
0
118,692
168,577
158,820
164,404
220,535
209,300
158,613
207,325
226,280
55,000
44,151
34,841
34,84144,15155,000226,280207,325158,613209,300220,535164,404158,820168,577118,6920000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
158,613
207,325
226,280
55,000
44,151
34,841
34,84144,15155,000226,280207,325158,6130000000000
       Accounts payable 
0
13,253
27,845
186,382
454,566
303,127
263,869
168,482
106,295
33,164
165,824
475,965
600,015
13,384
7,874
15,472
15,4727,87413,384600,015475,965165,82433,164106,295168,482263,869303,127454,566186,38227,84513,2530
       Other Current Liabilities 
0
8,666
11,577
28,015
13,109
10,238
12,178
23,561
614
1,861
-1
-1
238,255
8,005
0
18,481
18,48108,005238,255-1-11,86161423,56112,17810,23813,10928,01511,5778,6660
   > Long-term Liabilities 
0
61,442
36,358
132,376
30,124
39,774
58,895
80,119
79,945
113,680
79,629
78,166
88,748
20,244
21,377
33,520
33,52021,37720,24488,74878,16679,629113,68079,94580,11958,89539,77430,124132,37636,35861,4420
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
27,911
30,788
39,724
5,826
4,084
3,894
3,8944,0845,82639,72430,78827,9110000000000
> Total Stockholder Equity
0
65,552
69,370
198,893
201,788
207,756
219,620
224,387
232,725
236,656
240,781
250,940
238,159
113,555
109,568
108,649
108,649109,568113,555238,159250,940240,781236,656232,725224,387219,620207,756201,788198,89369,37065,5520
   Common Stock
0
36,704
36,704
169,404
169,404
169,404
169,404
169,404
169,404
169,404
169,404
169,404
169,404
81,314
81,314
81,314
81,31481,31481,314169,404169,404169,404169,404169,404169,404169,404169,404169,404169,40436,70436,7040
   Retained Earnings Total Equity0000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
2,123
2,123
6,453
6,453
6,453
6,4536,4536,4532,1232,12300000000000
   Capital Surplus 0000000000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
0
15,110
15,110
8,575
8,575
8,575
8,575
8,575
8,575
8,575
8,575
-242,364
6,453
-107,103
-1
-102,196
-102,196-1-107,1036,453-242,3648,5758,5758,5758,5758,5758,5758,5758,57515,11015,1100



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue60,203
Cost of Revenue-33,897
Gross Profit26,30626,306
 
Operating Income (+$)
Gross Profit26,306
Operating Expense-23,180
Operating Income2,7123,126
 
Operating Expense (+$)
Research Development0
Selling General Administrative1,775
Selling And Marketing Expenses1,293
Operating Expense23,1803,068
 
Net Interest Income (+$)
Interest Income196
Interest Expense-3,964
Other Finance Cost-196
Net Interest Income-3,964
 
Pretax Income (+$)
Operating Income2,712
Net Interest Income-3,964
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-8386,523
EBIT - interestExpense = -838
-838
3,295
Interest Expense3,964
Earnings Before Interest and Taxes (EBIT)3,1263,126
Earnings Before Interest and Taxes (EBITDA)5,627
 
After tax Income (+$)
Income Before Tax-838
Tax Provision--169
Net Income From Continuing Ops-669-669
Net Income-669
Net Income Applicable To Common Shares-936
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses57,077
Total Other Income/Expenses Net-3,8113,964
 

Technical Analysis of Ortin Laboratories Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ortin Laboratories Limited. The general trend of Ortin Laboratories Limited is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ortin Laboratories Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Ortin Laboratories Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 22.00 < 22.00 < 22.60.

The bearish price targets are: 18.55 > 16.20 > 16.20.

Tweet this
Ortin Laboratories Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Ortin Laboratories Limited. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Ortin Laboratories Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Ortin Laboratories Limited. The current macd is 0.11934328.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Ortin Laboratories Limited price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Ortin Laboratories Limited. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Ortin Laboratories Limited price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Ortin Laboratories Limited Daily Moving Average Convergence/Divergence (MACD) ChartOrtin Laboratories Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Ortin Laboratories Limited. The current adx is 20.72.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Ortin Laboratories Limited shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Ortin Laboratories Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Ortin Laboratories Limited. The current sar is 21.55.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Ortin Laboratories Limited Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Ortin Laboratories Limited. The current rsi is 53.60. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Ortin Laboratories Limited Daily Relative Strength Index (RSI) ChartOrtin Laboratories Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Ortin Laboratories Limited. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Ortin Laboratories Limited price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Ortin Laboratories Limited Daily Stochastic Oscillator ChartOrtin Laboratories Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Ortin Laboratories Limited. The current cci is 34.07.

Ortin Laboratories Limited Daily Commodity Channel Index (CCI) ChartOrtin Laboratories Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Ortin Laboratories Limited. The current cmo is 10.85.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Ortin Laboratories Limited Daily Chande Momentum Oscillator (CMO) ChartOrtin Laboratories Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Ortin Laboratories Limited. The current willr is -57.97101449.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Ortin Laboratories Limited is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Ortin Laboratories Limited Daily Williams %R ChartOrtin Laboratories Limited Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Ortin Laboratories Limited.

Ortin Laboratories Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Ortin Laboratories Limited. The current atr is 1.13617592.

Ortin Laboratories Limited Daily Average True Range (ATR) ChartOrtin Laboratories Limited Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Ortin Laboratories Limited. The current obv is 9,020,066.

Ortin Laboratories Limited Daily On-Balance Volume (OBV) ChartOrtin Laboratories Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Ortin Laboratories Limited. The current mfi is 52.31.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Ortin Laboratories Limited Daily Money Flow Index (MFI) ChartOrtin Laboratories Limited Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Ortin Laboratories Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Ortin Laboratories Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Ortin Laboratories Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.601
Ma 20Greater thanMa 5019.583
Ma 50Greater thanMa 10019.547
Ma 100Greater thanMa 20020.594
OpenGreater thanClose19.750
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Ortin Laboratories Limited with someone you think should read this too:
  • Are you bullish or bearish on Ortin Laboratories Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ortin Laboratories Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Ortin Laboratories Limited

I send you an email if I find something interesting about Ortin Laboratories Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Ortin Laboratories Limited.

Receive notifications about Ortin Laboratories Limited in your mailbox!